Nutritional Management for Patients with Head and Neck Cancer: The Second Step of an Italian Survey. The Opinion of Italian OtolaryngologistsMarianna Trignani1*, Melissa Laus2, Valentina Mastronardi2, Olga Leone2, Marilina De Rosa2, Giulio Campitelli2, Angelo Di Pilla1, Giuseppe Santarelli3, Albina Allajbej1, Ambra Pamio4, Domenico Genovesi1 and Adelchi Croce2
- *Corresponding Author:
- Marianna Trignani
Department of Radiotherapy, SS Annunziata
Hospital, Via Dei Vestini, 66100 Chieti, Italy
E-mail: [email protected]
Received date:: January 13, 2016 Accepted date:: February 10, 2016 Published date:: February 16, 2016
Citation: Trignani M, Laus M, Mastronardi V, Leone O, De Rosa M, et al. (2016) Nutritional Management for Patients with Head and Neck Cancer: The Second Step of an Italian Survey: The Opinion of Italian Otolaryngologists. Otolaryngol (Sunnyvale) 6:223. doi:10.4172/2161-119X.1000223
Copyright: © 2016 Trignani M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Backgrounds: The purpose of this study was to survey the opinion of Italian otolaryngologist about nutritional management in patients with head and neck tumors.
Materials and Methods: A survey of 10 questions was e-mailed to 100 Italian centers of Otolaryngology.
Results: A total of 27 surveys were filled in. Nutritional supplementation in preventive phase was used by 37% respondents. The majority of respondents (88.3%) stated to use percutaneous endoscopic gastrostomy (PEG) in a reactive phase. Nutritional counseling before starting treatment was performed “rarely” by 33.3% of respondents while “always” by 29.6% of respondents; however 85.2% of respondents stated that medical nutritionist assessment should represent a standard procedure before starting an oncologic treatment. Conclusions: Current practice about nutritional management for head and neck tumors is wide heterogeneous. Early or reactive approaches remain questionable, though otolaryngologists agree on the use of PEG in a reactive phase.